Chromogenic Substrates

Chromogenic substrates are compounds that produce a visible color change when acted upon by specific enzymes. These substrates are widely used in diagnostic assays, biochemical research, and enzyme-linked immunosorbent assays (ELISAs) to detect and quantify enzyme activity. The color change allows for easy and rapid visual identification of enzyme reactions, making chromogenic substrates essential tools in laboratory analysis. At CymitQuimica, we provide a diverse selection of high-quality chromogenic substrates to support your research and diagnostic applications.

20
- 50
- 100
- 200

products per page. 790 products on this category.

Product data	Purity	Price range	Estimated delivery
5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside REF: 3D-B-7134CAS: 1301706-80-8	- - -	To inquire	Wed 18 Dec 24
Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4673_P00CAS: 2484872-46-8	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4715_P00CAS: 2484873-16-5	Of Solute (Hplc) 95.0 To 100.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4672_P00CAS: 1254798-15-6	Min. 95 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside REF: 3D-B-7044	Min. 99.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4714_P00CAS: 2484873-15-4	Of Solute (Hplc) 98.0 To 100.0 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous REF: 3D-B-7398CAS: 129541-41-9	Min. 98.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4682_P00CAS: 2484872-49-1	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside REF: 3D-B-8932CAS: 212069-27-7	- - -	To inquire	Wed 18 Dec 24
Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4675_P00CAS: 2484872-47-9	Min. 95 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl butyrate REF: 3D-B-7050CAS: 129541-43-1	Min. 98.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4688_P00	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl myristate REF: 3D-B-7408CAS: 341972-95-0	Min. 98 Area-%	To inquire	Wed 18 Dec 24
Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4698_P00CAS: 2484872-58-2	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4678_P00CAS: 2484872-48-0	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl oleate REF: 3D-B-7412CAS: 341972-97-2	Min. 98 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl-α-D-N-acetylneuraminic acid, sodium salt REF: 3D-B-7040CAS: 160369-85-7	Min. 98.0 Area-%	To inquire	Wed 18 Dec 24
Aldol® 495 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4703_P00CAS: 2484872-62-8	Min. 95.0 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-galactopyranoside REF: 3D-B-7150CAS: 7240-90-6	Min. 99.0 Area-%	To inquire	Wed 18 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-xylopyranoside REF: 3D-B-7750CAS: 207606-55-1	- - -	To inquire	Wed 18 Dec 24

1g		To inquire
5g		To inquire
250mg		To inquire
500mg		To inquire
2500mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire
250mg		To inquire

Chromogenic Substrates

5-Bromo-4-chloro-3-indoxyl-α-D-fucopyranoside

Ref: 3D-B-7134

Aldol® 515 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4673_P00

Aldol® 495 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4715_P00

Aldol® 470 choline phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4672_P00

5-Bromo-4-chloro-3-indoxyl-α-L-arabinofuranoside

Ref: 3D-B-7044

Aldol® 458 nonanoate solution, 0.75 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4714_P00

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt anhydrous

Ref: 3D-B-7398

Aldol® 470 butyrate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4682_P00

6-Bromo-2-naphthyl-2-acetamido-2-deoxy-β-D-glucopyranoside

Ref: 3D-B-8932

Aldol® 518 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4675_P00

5-Bromo-4-chloro-3-indoxyl butyrate

Ref: 3D-B-7050

Aldol® 455 α-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4688_P00

5-Bromo-4-chloro-3-indoxyl myristate

Ref: 3D-B-7408

Aldol® 484 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4698_P00

Aldol® 470 phosphate, disodium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4678_P00

5-Bromo-4-chloro-3-indoxyl oleate

Ref: 3D-B-7412

5-Bromo-4-chloro-3-indoxyl-α-D-N-acetylneuraminic acid, sodium salt

Ref: 3D-B-7040

Aldol® 495 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4703_P00

5-Bromo-4-chloro-3-indoxyl-β-D-galactopyranoside

Ref: 3D-B-7150

5-Bromo-4-chloro-3-indoxyl-β-D-xylopyranoside

Ref: 3D-B-7750